762 results on '"Macular degeneration -- Reports"'
Search Results
202. Global Ophthalmic Drugs Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 5.3% - ResearchAndMarkets.com
203. GLOBAL JUVENILE DEGENERATION (STARGARDT DISEASE) MARKET RESEARCH REPORT- FORECAST TO 2027
204. GLOBAL JUVENILE DEGENERATION (STARGARDT DISEASE) MARKET RESEARCH REPORT- FORECAST TO 2027
205. Juvenile Macular Degeneration Market 7.2% CAGR Expected to Boost by 2023 | Industry Growth by Top Vendors Bayer HealthCare, F. Hoffmann-La Roche, Copernicus Therapeutics Inc and Grupo Ferrer Internaci
206. Regenerative Patch Technologies Announces Publication of Initial Results from Phase 1|2a Clinical Trial in Advanced Dry Age-Related Macular Degeneration
207. Regenerative Patch Technologies Announces Publication of Initial Results from Phase 1/2a Clinical Trial in Advanced Dry Age-Related Macular Degeneration
208. Global Age-related Macular Degeneration Partnering Deals and Agreements 2012-2018 - ResearchAndMarkets.com
209. Global Age-related Macular Degeneration Partnering Deals and Agreements 2012-018
210. Worldwide Juvenile Macular Degeneration Market is Estimated to Grow at a CAGR of 6.7% till 2023
211. FORM 8-K: Tracon Pharmaceuticals, Inc Files Current Report Updated on 28-02-18
212. Technavio Announces New Research on the Global Age-related Macular Degeneration Market
213. Patent Issued for Crystalline Forms Of 6-((6,7-Dimethoxyquinazolin-4-Yl)oxy)-N,2-Dimethylbenzofuran-3-Carboxamid- E (USPTO 10,519,142)
214. New Findings Reported from University of Oklahoma Describe Advances in Age-Related Macular Degeneration [Microvascular Contributions To Age-related Macular Degeneration (Amd): From Mechanisms of Choriocapillaris Aging To Novel Interventions]
215. New Proteome Research Reported from Buck Institute for Research on Aging (Proteome and Secretome Dynamics of Human Retinal Pigment Epithelium in Response to Reactive Oxygen Species)
216. New Findings from Thomas Jefferson University Hospital Describe Advances in Retinal Detachment (Rhegmatogenous Retinal Detachment after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor)
217. Studies from Indian Institute of Technology in the Area of Biopharmaceuticals Reported (QbD Based Media Development for the Production of Fab Fragments in E. coli)
218. Researchers from Institute of Materials Research and Engineering Detail Findings in Receptor Protein-Tyrosine Kinases (Sustained delivery of anti-VEGFs from thermogel depots inhibits angiogenesis without the need for multiple injections)
219. Investigators at All India Institute of Medical Sciences Discuss Findings in Anatomy (Localization of Nitro-tyrosine Immunoreactivity In Human Retina)
220. Patent Issued for Stable Liquid Formulations Of Recombinant Fusion Proteins (USPTO 10,293,045)
221. Reports from University of Eastern Finland Add New Data to Findings in Cell Biology (Sqstm1/p62 Regulates the Production of Il-8 and Mcp-1 In Il-1 Beta-stimulated Human Retinal Pigment Epithelial Cells)
222. Research and Markets Adds Report: Age Related Macular Degeneration - Pipeline Review, H2 2013
223. BioTrends Research Brings Out TreatmentTrends: Dry/Wet AMD (US) Report
224. Charity advises caution over aspirin link to AMD
225. Overview of Age Related Macular Degeneration - Pipeline Review, H2 2017
226. Overview of Age Related Macular Degeneration - Pipeline Review, H2 2017
227. United States : NIH discovery brings stem cell therapy for eye disease closer to the clinic
228. NIH discovery brings stem cell therapy for eye disease closer to the clinic
229. NIH DISCOVERY BRINGS STEM CELL THERAPY FOR EYE DISEASE CLOSER TO THE CLINIC
230. Lutein market projected to grow at a CAGR of 6.3%
231. Lutein Market Worth 357.7 Million USD by 2022
232. Global Age-related Macular Degeneration Partnering 2010 to 2017
233. Retinal Disorders Markets 2017: Treatment, Marketed Drugs, Pipeline - Research and Markets
234. Macular Degeneration (AMD) & Diabetic Retinopathy (DR) Market Forecast 2017-2027
235. Global Ophthalmics Partnering 2010-2017: Deal Trends, Players and Financials Analysis Report - Research and Markets
236. Ophthalmic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
237. Eylea Will Dominate The Wet Age-Related Macular Degeneration Market Until 2018, When Its Share Will Become Threatened By Emerging Products
238. Eylea Will Dominate The Wet Age-Related Macular Degeneration Market Until 2018, When Its Share Will Become Threatened By Emerging Products
239. New Study Finds No Additional Benefit from (RS) Meso-Zeaxanthin
240. Market Overview - Global Age-Related Macular Degeneration (AMD) Therapeutics Market Shares, Strategies Size And Forecasts Worldwide 2017 - By Acute Market Reports
241. Market Overview - Global Age-Related Macular Degeneration (AMD) Therapeutics Market Shares, Strategies Size And Forecasts Worldwide 2017 - By Acute Market Reports
242. Macular Degeneration (AMD) and Other Retinal Diseases: World Drug Industry and Market 2016-2026
243. Ophthalmic Lasers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts to 2024
244. Global Age - related Macular Degeneration Partnering 2010 to 2017
245. CAN FREQUENT ANTI-VEGF INJECTIONS INCREASE GLAUCOMA SURGERY RISK?
246. Global Age-Related Macular Degeneration Partnering Deals and Agreements Entered into by the World's Leading Healthcare Companies from 2010 to 2017 - Research and Markets
247. Global Age-related Macular Degeneration Partnering Deals and Agreements Entered into by the World's Leading Healthcare Companies from 2010 to 2017
248. Global Age-related Macular Degeneration Partnering Deals and Agreements Entered into by the World's Leading Healthcare Companies from 2010 to 2017
249. Age-Related Macular Degeneration (AMD): KOL Insight
250. Technology on test
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.